Stocks and Investing Stocks and Investing
Thu, July 6, 2023
[ 12:00 AM ] - WOPRAI
Gus Richard Maintained (tygo) at Buy with Increased Target to $25 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Laura Martin Reiterated (TTD) at Strong Buy and Held Target at $80 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (TRV) at Hold with Decreased Target to $176 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (TRV) at Sell with Increased Target to $194 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Whitney Ijem Reiterated (TSHA) at Strong Buy and Held Target at $13 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
John Murphy Maintained (TSLA) at Hold with Increased Target to $300 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Garrett Nelson Maintained (TSLA) at Strong Buy with Increased Target to $310 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Spiro Dounis Reiterated (TRGP) at Strong Buy and Held Target at $95 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Mitch Germain Reiterated (TRNO) at Buy and Held Target at $71 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Reiterated (ULCC) at Buy and Held Target at $19 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (UFCS) at Sell with Decreased Target to $22 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Henry Coffey Reiterated (UMH) at Buy and Held Target at $19 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (UNP) at Hold with Decreased Target to $168 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Reiterated (UPS) at Sell and Held Target at $100 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Alethia Young Reiterated (VSTM) at Buy and Held Target at $34 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Adrian Huerta Downgraded (VMC) to Hold and Increased Target to $230 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Reiterated (ALK) at Buy and Held Target at $75 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Barker Downgraded (AFRM) to Sell and Held Target at $11 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (ALGT) at Hold with Increased Target to $120 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Laws Downgraded (AJX) to Hold on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Paris Reiterated (UTI) at Buy and Held Target at $10 on, Jul 6th, 2023
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (UVE) at Buy with Decreased Target to $22 on, Jul 6th, 2023
Wed, July 5, 2023
[ 12:00 AM ] - WOPRAI
Brett Rabatin Downgraded (VBTX) to Hold and Held Target at $21 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Edward Reilly Initiated (USEG) at Strong Buy and Held Target at $3 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Nikhil Gupta Initiated (VAL) at Strong Buy and Held Target at $85 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Carlo Santarelli Downgraded (VICI) to Hold and Decreased Target to $34 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Laws Downgraded (AJX) to Hold on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Chiodo Maintained (AFRM) at Hold with Decreased Target to $15 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Kenneth Herbert Maintained (VSEC) at Buy with Increased Target to $63 on, Jul 5th, 2023
[ 12:00 AM ] - WOPRAI
Robert Burns Reiterated (VIRX) at Strong Buy with Decreased Target to $10 on, Jul 5th, 2023

Robert Burns Reiterated (VIRX) at Strong Buy with Decreased Target to $10 on, Jul 5th, 2023


Published on 2024-10-28 04:38:42 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "Viracta Therapeutics, Inc." (VIRX) at Strong Buy with Decreased Target from $33 to $10 on, Jul 5th, 2023.

Robert has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert

  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $7 on, Tuesday, May 9th, 2023
  • Andrew Berens of "SVB Securities" Maintained at Buy and Held Target at $11 on, Monday, May 8th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Monday, March 27th, 2023
Contributing Sources